Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin domain-containing protein 2 (TXNDC2) is an enzyme of the thioredoxin family that participates in redox homeostasis and protein-disulfide reduction, primarily in the testis. It is specifically expressed in spermatids and is thought to play a regulatory role in sperm development, potentially supporting the assembly of the fibrous sheath in the sperm tail. It is not currently considered a direct therapeutic target and has not been linked to specific drug interactions or safety concerns[2][3][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin domain-containing protein 2 (TXNDC2).